|
Peste des petits ruminants virus (PPRV) is a morbillivirus which causes disease in sheep and goats (shoats). Current live attenuated PPRV vaccines are effective but require a cold-chain for distribution and do not enable vaccinated animals to be distinguished from those which have recovered from disease. The purpose of the current project is to construct and test an alternative vaccine which promises to overcome these defects. The vaccine will be based on recombinant fowl poxviruses (rFPVs) expressing the surface glycoproteins of PPRV. These will be combined with other rFPVs expressing ovine cytokines in order to boost the immune response to the vaccine and to increase the chance that protection will be achieved with only a single dose of vaccine. The vaccine will be tested under controlled conditions at IAH and in native shoats in Uganda. In addition, new assays will be developed to assist in PPRV disease control programmes. A new diagnostic ELISA will be developed to complement the new vaccine, and which will enable infected animals to be distinguished from vaccinated animals. The project will be associated with a commercial partner in order to develop a pen-side test for PPRV, which can be used to rapidly check for PPRV infection in the field. We will work with our Ugandan partners to acquire data on the distribution of PPRV and other shoat diseases and to uplift their diagnostic capabilities.
IAH Principal Investigator: Dr Michael Baron IAH Co-investigators: Dr. Chris Oura, Dr Geraldine Taylor Overseas Collaborators: Dr. Anna Rose Ademun Okurut, Diagnostics and Epidemiology Centre (DEC), Ministry of Agriculture, Animal Industry and Fisheries, P.O. Box 513, Entebbe, Uganda Dr. Chrisostom Ayebazibwe Diagnostics and Epidemiology Centre (DEC), Ministry of Agriculture, Animal Industry and Fisheries, P.O. Box 513, Entebbe, Uganda Project Partners: Jenner Institute, University of Oxford Svanova AB, Sweden Susanne Grange, FAO Uganda Keith Hamilton, OIE Paris. Country involved: Uganda Duration: 48 months |
||